Interesting multi-center RCT that paves the way for potential paradigm shifts in antithrombotic modulation. The abcence of symptomatic pulmonary embolism warrants further investigation…
Abelacimab for Prevention of Venous Thromboembolism
Submitted by: Aristotle Protopapas
Source: The New England Journal of Medicine
Keywords:
Author(s): Peter Verhamme, B. Alexander Yi,Annelise Segers, Janeen Salter, Daniel Bloomfield, Harry R. Büller, Gary E. Raskob, Jeffrey I. Weitz